Study | Center | Country | No. of patients | Age | Type of surgery | Type of corticosteroids | Timing | Regimen | Control |
---|---|---|---|---|---|---|---|---|---|
Ando2005 [34] | 1 | Japan | 20(10/10) |  ≤ 28 days | complete biventricular repair | hydrocortisone | intraoperative, postoperative | 0.18 mg/kg/h for 3 days, 0.09 mg/kg/h for 2 days, 0.045 mg/kg/h for 2 day | placebo |
Graham2019 [29] | 2 | US | 176(81/95) |  ≤ 31 days | miscellaneous | methylprednisolone | intraoperative | 30 mg/kg, after induction of anesthesia | placebo |
Heying2012 [14] | 1 | Germany | 20(9/11) | 8-21Â days | arterial switch | dexamethasone | preoperative | 1Â mg/kg, 4Â h before scheduled start of CPB | placebo |
Hill2022 [16] | 24 | US | 1200(599/601) |  < 1 year | miscellaneous | methylprednisolone | intraoperative | 30 mg/kg, CPB pump-priming fluid | placebo |
Keski-Nisula2013 [35] | 1 | Finland | 40(20/20) |  ≤ 28 days | miscellaneous | methylprednisolone | intraoperative | 30 mg/kg, after induction of anesthesia | placebo |
Keski-Nisula2020 [36] | 1 | Finland | 30(15/15) | 2-12Â months | bidirectional Glenn procedure | methylprednisolone | intraoperative | 30Â mg/kg, after induction of anesthesia | placebo |
Lomivorotov2020 [30] | 4 | Brazil, China, Russia | 394(194/200) |  ≤ 12 months | not reported | dexamethasone | intraoperative | 1 mg/kg, after induction of anesthesia | placebo |
Suominen2017 [37] | 1 | Finland | 40(20/20) |  ≤ 28 days | miscellaneous | methylprednisolone, hydrocortisone | intraoperative, postoperative | 2 mg/kg methylprednisolone after induction, hydrocortisone infusion 0.2 mg/kg/h for 48 h, 0.1 mg/kg/h for 48 h, and 0.05 mg/kg/h for 24 h | placebo |